Literature DB >> 25941339

An information theoretic method to identify combinations of genomic alterations that promote glioblastoma.

Rachel D Melamed1, Jiguang Wang1, Antonio Iavarone2, Raul Rabadan3.   

Abstract

Tumors are the result of accumulated genomic alterations that cooperate synergistically to produce uncontrollable cell growth. Although identifying recurrent alterations among large collections of tumors provides a way to pinpoint genes that endow a selective advantage in oncogenesis and progression, it fails to address the genetic interactions behind this selection process. A non-random pattern of co-mutated genes is evidence for selective forces acting on tumor cells that harbor combinations of these genetic alterations. Although existing methods have successfully identified mutually exclusive gene sets, no current method can systematically discover more general genetic relationships. We develop Genomic Alteration Modules using Total Correlation (GAMToC), an information theoretic framework that integrates copy number and mutation data to identify gene modules with any non-random pattern of joint alteration. Additionally, we present the Seed-GAMToC procedure, which uncovers the mutational context of any putative cancer gene. The software is publicly available. Applied to glioblastoma multiforme samples, GAMToC results show distinct subsets of co-occurring mutations, suggesting distinct mutational routes to cancer and providing new insight into mutations associated with proneural, proneural/G-CIMP, and classical types of the disease. The results recapitulate known relationships such as mutual exclusive mutations, place these alterations in the context of other mutations, and find more complex relationships such as conditional mutual exclusivity.
© The Author (2015). Published by Oxford University Press on behalf of Journal of Molecular Cell Biology, IBCB, SIBS, CAS. All rights reserved.

Entities:  

Keywords:  cancer; cancer genetics; copy number; entropy; genomics; sequencing

Mesh:

Year:  2015        PMID: 25941339      PMCID: PMC4565985          DOI: 10.1093/jmcb/mjv026

Source DB:  PubMed          Journal:  J Mol Cell Biol        ISSN: 1759-4685            Impact factor:   6.216


  35 in total

1.  A novel signaling pathway impact analysis.

Authors:  Adi Laurentiu Tarca; Sorin Draghici; Purvesh Khatri; Sonia S Hassan; Pooja Mittal; Jung-Sun Kim; Chong Jai Kim; Juan Pedro Kusanovic; Roberto Romero
Journal:  Bioinformatics       Date:  2008-11-05       Impact factor: 6.937

2.  Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.

Authors:  Houtan Noushmehr; Daniel J Weisenberger; Kristin Diefes; Heidi S Phillips; Kanan Pujara; Benjamin P Berman; Fei Pan; Christopher E Pelloski; Erik P Sulman; Krishna P Bhat; Roel G W Verhaak; Katherine A Hoadley; D Neil Hayes; Charles M Perou; Heather K Schmidt; Li Ding; Richard K Wilson; David Van Den Berg; Hui Shen; Henrik Bengtsson; Pierre Neuvial; Leslie M Cope; Jonathan Buckley; James G Herman; Stephen B Baylin; Peter W Laird; Kenneth Aldape
Journal:  Cancer Cell       Date:  2010-04-15       Impact factor: 31.743

3.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

Authors:  Roel G W Verhaak; Katherine A Hoadley; Elizabeth Purdom; Victoria Wang; Yuan Qi; Matthew D Wilkerson; C Ryan Miller; Li Ding; Todd Golub; Jill P Mesirov; Gabriele Alexe; Michael Lawrence; Michael O'Kelly; Pablo Tamayo; Barbara A Weir; Stacey Gabriel; Wendy Winckler; Supriya Gupta; Lakshmi Jakkula; Heidi S Feiler; J Graeme Hodgson; C David James; Jann N Sarkaria; Cameron Brennan; Ari Kahn; Paul T Spellman; Richard K Wilson; Terence P Speed; Joe W Gray; Matthew Meyerson; Gad Getz; Charles M Perou; D Neil Hayes
Journal:  Cancer Cell       Date:  2010-01-19       Impact factor: 31.743

4.  A human functional protein interaction network and its application to cancer data analysis.

Authors:  Guanming Wu; Xin Feng; Lincoln Stein
Journal:  Genome Biol       Date:  2010-05-19       Impact factor: 13.583

5.  Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM.

Authors:  Charles J Vaske; Stephen C Benz; J Zachary Sanborn; Dent Earl; Christopher Szeto; Jingchun Zhu; David Haussler; Joshua M Stuart
Journal:  Bioinformatics       Date:  2010-06-15       Impact factor: 6.937

6.  Automated network analysis identifies core pathways in glioblastoma.

Authors:  Ethan Cerami; Emek Demir; Nikolaus Schultz; Barry S Taylor; Chris Sander
Journal:  PLoS One       Date:  2010-02-12       Impact factor: 3.240

7.  Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma.

Authors:  Rameen Beroukhim; Gad Getz; Leia Nghiemphu; Jordi Barretina; Teli Hsueh; David Linhart; Igor Vivanco; Jeffrey C Lee; Julie H Huang; Sethu Alexander; Jinyan Du; Tweeny Kau; Roman K Thomas; Kinjal Shah; Horacio Soto; Sven Perner; John Prensner; Ralph M Debiasi; Francesca Demichelis; Charlie Hatton; Mark A Rubin; Levi A Garraway; Stan F Nelson; Linda Liau; Paul S Mischel; Tim F Cloughesy; Matthew Meyerson; Todd A Golub; Eric S Lander; Ingo K Mellinghoff; William R Sellers
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-06       Impact factor: 11.205

8.  AlphaII-spectrin is critical for cell adhesion and cell cycle.

Authors:  Sylvain Metral; Beata Machnicka; Sylvain Bigot; Yves Colin; Didier Dhermy; Marie-Christine Lecomte
Journal:  J Biol Chem       Date:  2008-10-31       Impact factor: 5.157

9.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

10.  Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis.

Authors:  Haihao Zhu; Jaime Acquaviva; Pranatartiharan Ramachandran; Abraham Boskovitz; Steve Woolfenden; Rolf Pfannl; Roderick T Bronson; John W Chen; Ralph Weissleder; David E Housman; Al Charest
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-05       Impact factor: 11.205

View more
  6 in total

1.  Clonal evolution of glioblastoma under therapy.

Authors:  Jiguang Wang; Emanuela Cazzato; Erik Ladewig; Veronique Frattini; Daniel I S Rosenbloom; Sakellarios Zairis; Francesco Abate; Zhaoqi Liu; Oliver Elliott; Yong-Jae Shin; Jin-Ku Lee; In-Hee Lee; Woong-Yang Park; Marica Eoli; Andrew J Blumberg; Anna Lasorella; Do-Hyun Nam; Gaetano Finocchiaro; Antonio Iavarone; Raul Rabadan
Journal:  Nat Genet       Date:  2016-06-06       Impact factor: 38.330

2.  EZH2-, CHD4-, and IDH-linked epigenetic perturbation and its association with survival in glioma patients.

Authors:  Le Zhang; Ying Liu; Mengning Wang; Zhenhai Wu; Na Li; Jinsong Zhang; Chuanwei Yang
Journal:  J Mol Cell Biol       Date:  2017-12-01       Impact factor: 6.216

3.  TumorMap: Exploring the Molecular Similarities of Cancer Samples in an Interactive Portal.

Authors:  Yulia Newton; Adam M Novak; Teresa Swatloski; Duncan C McColl; Sahil Chopra; Kiley Graim; Alana S Weinstein; Robert Baertsch; Sofie R Salama; Kyle Ellrott; Manu Chopra; Theodore C Goldstein; David Haussler; Olena Morozova; Joshua M Stuart
Journal:  Cancer Res       Date:  2017-11-01       Impact factor: 12.701

4.  Discovery of cancer common and specific driver gene sets.

Authors:  Junhua Zhang; Shihua Zhang
Journal:  Nucleic Acids Res       Date:  2017-06-02       Impact factor: 16.971

5.  Cancer classification and pathway discovery using non-negative matrix factorization.

Authors:  Zexian Zeng; Andy H Vo; Chengsheng Mao; Susan E Clare; Seema A Khan; Yuan Luo
Journal:  J Biomed Inform       Date:  2019-07-02       Impact factor: 6.317

6.  Deep learning for cancer type classification and driver gene identification.

Authors:  Zexian Zeng; Chengsheng Mao; Andy Vo; Xiaoyu Li; Janna Ore Nugent; Seema A Khan; Susan E Clare; Yuan Luo
Journal:  BMC Bioinformatics       Date:  2021-10-25       Impact factor: 3.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.